Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
grade A 69.05 0.38% 0.26
ABT closed up 0.38 percent on Friday, September 21, 2018, on 1.91 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ABT trend table...

Date Alert Name Type % Chg
Sep 21 New 52 Week Closing High Bullish 0.00%
Sep 21 Pocket Pivot Bullish Swing Setup 0.00%
Sep 21 Narrow Range Bar Range Contraction 0.00%
Sep 21 NR7 Range Contraction 0.00%
Sep 21 New 52 Week High Strength 0.00%
Sep 21 Upper Bollinger Band Walk Strength 0.00%
Sep 21 Overbought Stochastic Strength 0.00%
Sep 21 Up 3 Days in a Row Strength 0.00%
Sep 21 Up 4 Days in a Row Strength 0.00%
Sep 21 Upper Bollinger Band Touch Strength 0.00%

Older signals for ABT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Is ABT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 69.25
52 Week Low 51.2943
Average Volume 4,816,720
200-Day Moving Average 61.4103
50-Day Moving Average 65.5532
20-Day Moving Average 67.2665
10-Day Moving Average 67.946
Average True Range 0.7605
ADX 24.63
+DI 33.715
-DI 17.8624
Chandelier Exit (Long, 3 ATRs ) 66.9685
Chandelier Exit (Short, 3 ATRs ) 66.7585
Upper Bollinger Band 69.2277
Lower Bollinger Band 65.3053
Percent B (%b) 0.95
BandWidth 5.831134
MACD Line 0.9714
MACD Signal Line 0.8388
MACD Histogram 0.1326
Fundamentals Value
Market Cap 119.97 Billion
Num Shares 1.74 Billion
EPS 0.71
Price-to-Earnings (P/E) Ratio 97.25
Price-to-Sales 4.08
Price-to-Book 3.05
PEG Ratio 1.87
Dividend 1.06
Dividend Yield 1.54%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 69.61
Resistance 3 (R3) 69.61 69.43 69.51
Resistance 2 (R2) 69.43 69.29 69.43 69.48
Resistance 1 (R1) 69.24 69.20 69.34 69.24 69.45
Pivot Point 69.06 69.06 69.11 69.06 69.06
Support 1 (S1) 68.87 68.92 68.97 68.87 68.65
Support 2 (S2) 68.69 68.83 68.69 68.62
Support 3 (S3) 68.50 68.69 68.59
Support 4 (S4) 68.50